WHO ICTRP trial
Imiquimod versus PDT for actinic keratoses in in organ transplant recipients
EUCTR2012-000263-24-AT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-000263-24-AT |
|---|---|
| Public title | Imiquimod versus PDT for actinic keratoses in in organ transplant recipients |
| Scientific title | Comparative study for efficacy and tolerability of topical imiquimod 5% cream therapy versus photodynamic therapy (ALA-PDT) of actinic keratoses on the hands and forearms in organ transplant recipients - Imiquimod versus PDT für AK bei OTP |
| Primary sponsor | Medizinische Universität Wien, Univ. Klinik f. Dermatologie |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Austria |
| Conditions | actinic keratoses MedDRA version: 14.1 Level: PT Classification code 10000614 Term: Actinic keratosis System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Trade Name: ALACARE Product Name: 5-Amonolevulinic acid Product Code: 5-ALA Pharmaceutical Form: Cream INN or Proposed INN: 5-Aminolevulinic acid CAS Number: 106-60-5 Concentration unit: % percent Concentration type: equal Concentration… |
| Registration date | May 29, 2012 |
| Target size | 30 |
| Secondary IDs | IPOT2_01.05.2011 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: